Look for Drugs and Conditions



It is GnRH antagonist, which causes minimal histamine release, used for prostate cancer.


Advanced prostate cancer.


Subcutaneous; given in abdomen region, starting dose is 240mg in two doses, while maintenance dose is 80mg administered every 28 days.


Known hypersensitivity to degarelix, pregnancy.

Special Precautions

Paediatric: Safety and effectiveness in paediatric group not yet established. Pregnancy: Contraindicated. Lactation: Not known if excereted in milk. Elderly: Increase sensitivity, use with caution.

Side Effects

Pain, erythema , swelling, induration  and nodule at the site , weight increase, fatigue, chills, hot flushes, increased liver enzymes, hypertension, arthralgia.

Drug Interactions

Data not sufficient.

Other Brands With Same Generic
Brand Name Manufactured by
DEGAPRIDE Sun Pharmaceutical Industries Ltd.
Ad 5